Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Assets Average (2016 - 2026)

Iradimed has reported Assets Average over the past 13 years, most recently at $111.6 million for Q1 2026.

  • Quarterly Assets Average rose 11.55% to $111.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $111.6 million through Mar 2026, up 11.55% year-over-year, with the annual reading at $103.6 million for FY2025, 8.73% up from the prior year.
  • Assets Average was $111.6 million for Q1 2026 at Iradimed, roughly flat from $111.7 million in the prior quarter.
  • Over five years, Assets Average peaked at $111.7 million in Q4 2025 and troughed at $74.1 million in Q2 2022.
  • The 5-year median for Assets Average is $89.8 million (2023), against an average of $91.2 million.
  • Year-over-year, Assets Average increased 0.24% in 2022 and then increased 20.07% in 2025.
  • A 5-year view of Assets Average shows it stood at $82.5 million in 2022, then increased by 8.79% to $89.8 million in 2023, then rose by 7.25% to $96.3 million in 2024, then rose by 16.06% to $111.7 million in 2025, then fell by 0.15% to $111.6 million in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Assets Average are $111.6 million (Q1 2026), $111.7 million (Q4 2025), and $110.6 million (Q3 2025).